|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pituitary tumors and pregnancy:the interptaybetween a pathologic con- dition and a physiologic status显示文摘 | Pivonello R De Martino MC Auriemma RS | 2014 | J Endocrinol Invest2014，37，： | 1 |
| 2 | Pituitary carcinomas显示文摘 | Colao A Ochoa AS Auriemma RS | 2010 | Front Horm Res2010，38，： | 1 |
| 3 | Results of a single- center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation 显示文摘 | Auriemma RS Perone Y Di Sarno A | 2013 | J Clin Endocrinol Metab2013，98，1： | 1 |
| 4 | Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin ana- log treatment : effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 显示文摘 | Colao A Pivonello R Auriemma RS | 2006 | Eur J Endocrinol2006，154，3： | 1 |
| 5 | Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly :a prospective study in 99 patients 显示文摘 | Colao A Pivonello R Auriemma RS | 2006 | J Clin Endocrinol Metab2006，91，： | 1 |
| 6 | Efficacy of 12- month treatment with the GH receptor antagonistpegviso- mant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance 显示文摘 | Colao A Pivonello R Auriemma RS | 2006 | Eur J endocrinol2006，154，： | 1 |
| 7 | Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance 显示文摘 | Pivonello R Galderisi M Auriemma RS | 2007 | J Clin Endocrinol Metab2007，92，： | 1 |
| 8 | Resistance to so- matostatin analogs in acromegaly 显示文摘 | Colao A Auriemma RS Lombardi G | 2011 | Endocr Rev2011，32，2： | 1 |
| 9 | Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: a prospective study in 99 patients 显示文摘 | Colao A Pivonello R Auriemma RS | 2006 | J Clin Endoerinol Metab2006，91，6： | 1 |
| 10 | Second attempt to withdraw cabergoline in prolaetinomas: a pilot study显示文摘 | KWANCHAROEN R AURIEMMA RS YENOKYAN G | 2014 | Pituitary2014，17，5： | 1 |
| 11 | Pituitary carcinomas 显示文摘 | Colao A Ochoa AS Auriemma RS | 2010 | Front Horm Res2010，38，： | 1 |
| 12 | Effects of initial therapy for five years with somatostatin analogs for aeromegaly on growth hormone and insulin-like growth factor-I levels, tumor shrinkage, and cardiovascular disease : a prospective study 显示文摘 | Colao A Auriemma RS Galdiero M | 2009 | J Clin Endocrinol Metab2009，94，10： | 1 |
| 13 | Beneficial effect of dose escalation of octreotide-LAR as first-line therapy in patients with acromegaly 显示文摘 | Colao A Pivonello R Auriemma RS | 2007 | Eur J Endocrinol2007，157，5： | 1 |
| 14 | Effects of initial therapyfor five years with somatostatin analogs for acromegaly ongrowth hormone and insulin-like growth factor-I levels,tumorshrinkage,and cardiovascular disease:a prospective study显示文摘 | Colao A Auriemma RS Galdiero M | 2009 | JClin Endocrinol Metab2009，94，10： | 1 |
| 15 | The association of fasting insulin concentrations and colonic neoplasms in acromegaly: a colonoscopy-based study in 210 patients 显示文摘 | Colao A Pivonello R Auriemma RS | 2007 | J Clin Endocrinol Metab2007，92，10： | 1 |
| 16 | The safety of treatments for prolactinomas 显示文摘 | AURIEMMA RS GRASSO LF PIVONELLO R | 2016 | Expert Opin Drug Saf2016，15，4： | 1 |
| 17 | Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas显示文摘 | Auriemma RS Pivonello R Perone Y | 2013 | Eur J Endocrinol2013，169，3： | 1 |
| 18 | Evaluation of theretinal nerve fibre layer and ganglion cell complex thickness inpituitary macroadenomas without optic chiasmal compression显示文摘 | Cennamo G Auriemma RS Cardone D | 2015 | Eye (Lond)2015，29，6： | 1 |
| 19 | The safety of treatments for prolactinomas 显示文摘 | Auriemma RS Grasso LF Pivonello R | 2016 | Expert Opin Drug Saf2016，15，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员